Agenda – Preventing Adverse Drug Events (ADEs): Measuring Progress on the ADE Action Plan

Presentation	Content	Presenter
Introduction	Describe ADEs Explain why and how the ADE Action Plan was created Introduce 2020 targets and measures	Don Wright (ODPHP)
Inpatient Surveillance	Describe inpatient data collection	Noel Eldridge (AHRQ)
Outpatient Surveillance	Describe outpatient data collection	Andrew Geller (CDC)
Opioids	Describe opioids FIW efforts	Friedhelm Sandbrink (VHA)
Diabetes Agents	Describe diabetes FIW efforts	Christine Lee (FDA)
Anticoagulants	Describe anticoagulants FIW efforts	Nadine Shehab (CDC)
Incentives and Oversight	Describe new CMS quality payment incentives	Lemeneh Tefera (CMS)
Q&A	Audience Q&A with pre-written questions as backup	Clydette Powell (ODPHP)
Adjourn		Clydette Powell (ODPHP)